Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

AASLD: Successful HCV Tx cuts deaths post-transplant

Editor's pick
MedPage Today
1 November 2010
Hepatitis C treatment

Gilead presents phase IIa data for HCV therapy at The Liver Meeting 2010

Editor's pick
The Medical News
1 November 2010
Hepatitis C treatment

Longer Hep C Treatment Improves Response in People Coinfected With HIV

Editor's pick
AIDSMeds
1 November 2010
Hepatitis C treatment

Black patients fare well on Vertex hepatitis C drug

Editor's pick
Reuters
31 October 2010
New & experimental hepatitis C treatment

Investigational drug for hepatitis C boceprevir achieved significantly higher sustained virologic response rates compared to control

Editor's pick
Digital Journal
31 October 2010
Hepatitis C treatment

Bristol-Myers, Gilead seek AIDS cocktail success in hepatitis C

Editor's pick
Bloomberg
30 October 2010
Hepatitis C treatment

Hepatitis C drug pipeline analysis and market forecasts to 2016

Editor's pick
Press release
27 October 2010
Hepatitis C treatment

Vertex Pharmaceuticals highlights progress in hepatitis C drug development

Editor's pick
Vertex
27 October 2010
Hepatitis C transmission & prevention

Gladstone scientists link hepatitis C virus infection to fat enzyme in liver cells

Editor's pick
Eurekalert Medicine & Health
10 October 2010
Hepatitis C treatment

NICE’s publishes 200th guidance to better tackle Hepatitis C

Editor's pick
Pharma Times
27 September 2010
Hepatitis C treatment

Taribavirin offers a safe, effective alternative for chronic hepatitis C

Editor's pick
Eurekalert Medicine & Health
22 September 2010
Hepatitis C treatment

Partial hep C treatment response offers health benefits

Editor's pick
AIDSMeds.com
20 September 2010
New & experimental hepatitis C treatment

Vertex releases results of phase III study of telaprevir in hepatitis C

Editor's pick
Business Wire
10 August 2010
Hepatitis C treatment

Depression overlooked in patients with hepatitis C; compromising HCV therapy

Editor's pick
Eurekalert Medicine & Health
20 July 2010
Hepatitis C treatment

Medivir reports 24-week interim phase 2b results of TMC-435 in treatment-naive patients with HCV genotype 1

Editor's pick
The Medical News
12 July 2010